Valuation: IRIDEX Corporation

Market Cap 19.93M 17.45M 16.1M 15.02M 28.3M 1.88B 28.81M 193M 74.99M 930M 74.88M 73.21M 3.24B P/E 2026 *
-22.9x
P/E 2027 * 57.3x
Enterprise Value 19.93M 17.45M 16.1M 15.02M 28.3M 1.88B 28.81M 193M 74.99M 930M 74.88M 73.21M 3.24B EV / Sales 2026 *
0.38x
EV / Sales 2027 * 0.35x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day+0.88%
1 week-2.97%
1 month+9.05%
3 months+13.37%
6 months+0.44%
Current year+0.44%
1 week 1.12
Extreme 1.12
1.2
1 month 1.09
Extreme 1.09
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2022-03-16
Chairman 77 2010-08-31
Chairman 60 2020-06-23
Date Insider Type Main position Quantity % Market Cap.
Jun. 12Tax

Chief Executive Officer

-3,990 0.0229%
Jun. 12Tax

Chief Financial Officer

-2,691 0.0155%
Jun. 11Buy

Chief Financial Officer

975 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%-2.97%+29.83%-47.24% 19.93M
-1.00%+6.82%+23.65%-3.91% 186B
-2.04%-1.36%-26.82%+16.30% 141B
-1.19%+6.43%-3.57%-20.63% 135B
-1.84%-6.40%-60.26%-21.09% 63.44B
-0.79%+4.04%+15.66%-4.10% 52.09B
-0.75%-1.11%-27.86%-33.21% 43.6B
-.--%+4.86%+12.56%+10.46% 37.52B
+1.67%+4.99%+7.45%+40.71% 36.82B
-1.60%+0.46%-13.58%-21.21% 29.12B
Average -0.16%+2.01%-4.29%-8.39% 72.46B
Weighted average by Cap. -0.42%+3.86%-5.14%-4.06%

Financials

2026 *2027 *
Net sales 53M 46.39M 42.82M 39.95M 75.27M 5.01B 76.61M 514M 199M 2.47B 199M 195M 8.61B 56.77M 49.69M 45.87M 42.78M 80.61M 5.37B 82.06M 550M 214M 2.65B 213M 209M 9.23B
Net income -795K -696K -642K -599K -1.13M -75.17M -1.15M -7.71M -2.99M -37.09M -2.99M -2.92M -129M 361K 316K 292K 272K 513K 34.13M 522K 3.5M 1.36M 16.84M 1.36M 1.33M 58.68M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-06-30 $1.145 +0.88% 23,577
26-06-29 $1.135 +0.44% 57,032
26-06-26 $1.130 -4.24% 29,320
26-06-25 $1.180 -0.84% 42,752
26-06-24 $1.190 +0.85% 22,719
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.145USD
Average target price
2.750USD
Spread / Average Target
+140.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock